One-two punch vs. Parkinson's: meds and a machine
Posted 09 July 2013 - 06:43 PM
By Rick Ruggles / World-Herald staff writer
July 1, 2013
An Omaha scientist will start a human trial this summer involving the novel use of a drug that he hopes will halt the progress of Parkinson's disease.
The trial will include 16 patients with Parkinson's and 16 who don't have the progressive disease, which causes shaking, stiffness, trouble walking, balance problems and other difficulties.
The project is the first step in what Dr. Howard Gendelman envisions as a two-stage process to first halt the disease's progress and then, eventually, to defeat the protein-gone-bad that causes it.
“We hope to cure Parkinson's disease,” said Gendelman, chairman of pharmacology and experimental neuroscience at the University of Nebraska Medical Center. “I know it's a lofty goal.”
Kathrynne Holden, MS
<!-- m -->http://www.nutritionucanlivewith.com/<!-- m -->
Posted 10 July 2013 - 03:29 PM
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users